- Accueil
- Chercheurs
- Dr Vincent Laroche
Dr Vincent Laroche
Publications
9- Pettigrew M, Garces K, Deuson R, Kassis J, Laroche V. Comparative net cost impact of the utilization of romiplostim and intravenous immunoglobulin for the treatment of patients with immune thrombocytopenia in Québec, Canada.. J Med Econ 2013; 16(2):318-26.
- Rioux-Massé B, Laroche V, Bowman RJ, Lindgren BR, Cohn CS, Pulkrabek SM, McCullough J. The influence of bleeding on trigger changes for platelet transfusion in patients with chemotherapy-induced thrombocytopenia.. Transfusion 2013; 53(2):306-14.
- De Larochellière H, Urena M, Amat-Santos IJ, Ribeiro HB, Allende R, Laflamme L, Laflamme J, Paradis JM, Dumont E, Doyle D, Mohammadi S, De Larochellière R, Côté M, Laroche V, Rodés-Cabau J. Effect on outcomes and exercise performance of anemia in patients with aortic stenosis who underwent transcatheter aortic valve replacement.. Am J Cardiol 2015; 115(4):472-9.
- Laflamme J, Puri R, Urena M, Laflamme L, De Larochellière H, Abdul-Jawad Altisent O, Del Trigo M, Campelo-Parada F, De Larochellière R, Paradis JM, Dumont E, Doyle D, Mohammadi S, Côté M, Pibarot P, Laroche V, Rodés-Cabau J. Incidence and Risk Factors of Hemolysis After Transcatheter Aortic Valve Implantation With a Balloon-Expandable Valve.. Am J Cardiol 2015; 115(11):1574-9.
- Pendergrast J, Willie-Ramharack K, Sampson L, Laroche V, Branch DR. The role of inflammation in intravenous immune globulin-mediated hemolysis.. Transfusion 2015; 55(0):S65-73.
- Urena M, Del Trigo M, Altisent OA, Campelo-Prada F, Regueiro A, De Larochellière R, Doyle D, Mohammadi S, Paradis JM, Dagenais F, Dumont E, Puri R, Laroche V, Rodés-Cabau J. Combined erythropoietin and iron therapy for anaemic patients undergoing transcatheter aortic valve implantation: the EPICURE randomised clinical trial.. EuroIntervention 2017; 13(1):44-52.
- Patriquin CJ, Laroche V, Selby R, Pendergrast J, Barth D, Côté B, Gagnon N, Roberge G, Carrier M, Castellucci LA, Scarvelis D, Mack JP. Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia.. N Engl J Med 2021; 385(9):857-859.
- Turgeon AF, Fergusson DA, Clayton L, Patton MP, Zarychanski R, English S, Docherty A, Walsh T, Griesdale D, Kramer AH, Scales D, Burns KEA, Boyd JG, Marshall JC, Kutsogiannis DJ, Ball I, Hébert PC, Lamontagne F, Costerousse O, St-Onge M, Lessard Bonaventure P, Moore L, Neveu X, Rigamonti A, Khwaja K, Green RS, Laroche V, Fox-Robichaud A, Lauzier F. Haemoglobin transfusion threshold in traumatic brain injury optimisation (HEMOTION): a multicentre, randomised, clinical trial protocol.. BMJ Open 2022; 12(10):e067117.
- Pelland AA, Deschênes-Simard X, Savard X, Giguère P, Spillane D, Barabé F, Laroche V, Munger M, Gallagher G, Marcoux N, Cantin G, Chénard-Poirier M, Delage R, Lalancette M, Veilleux O, Assouline SE, Lemieux C. Outcomes of adults with refractory or relapsed acute myeloid leukemia treated with azacitidine and venetoclax compared to other therapies: a multicenter retrospective study.. Leuk Lymphoma 2024; 65(13):1974-1982.
Soutenir la médecine
de demain, maintenant.
Posez ce geste et faites la différence aujourd'hui. Au-devant, ensemble.